This company has been marked as potentially delisted and may not be actively trading. Reata Pharmaceuticals (RETA) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock RETA Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Arbe Robotics (NASDAQ:ARBE) Stock Quotes, Forecast and News SummaryNovember 1, 2024 | benzinga.comWhat to Know: How Israel Could Retaliate Against IranOctober 27, 2024 | nytimes.comLazard hires veteran healthcare dealmaker Colocci as vice chairmanMay 9, 2024 | investing.comLevi & Korsinsky, LLP Notifies Shareholders of Reata Pharmaceuticals, Inc. (RETA) an Upcoming Claims Deadline in a Class Action SettlementJanuary 25, 2024 | markets.businessinsider.comUpward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024December 29, 2023 | msn.comBiogen cuts annual profit forecast on higher deal costs (Nov 8)November 14, 2023 | investing.comBiogen lowers full-year earnings guidance, 3Q revenue beats expectationsNovember 8, 2023 | proactiveinvestors.comBiogen cuts annual profit forecast as higher costs persistNovember 8, 2023 | investing.comBraun Stacey Associates Inc. Lowers Stake in Reata Pharmaceuticals, Inc. (NASDAQ:RETA)October 13, 2023 | marketbeat.comReata Pharmaceuticals, Inc. (NASDAQ:RETA) Given Consensus Recommendation of "Hold" by BrokeragesOctober 13, 2023 | marketbeat.comTop Growth Stocks for October 2023October 1, 2023 | msn.comBiogen Inc.: Biogen Completes Acquisition of Reata PharmaceuticalsSeptember 26, 2023 | finanznachrichten.deBiogen Completes Acquisition of Reata PharmaceuticalsSeptember 26, 2023 | finance.yahoo.comReata Pharmaceuticals (Nasdaq:RETA) HeadlineTrading was temporarily halted for "RETA" at 07:09 PM with a stated reason of "News pending."...September 26, 2023 | marketbeat.comReata Pharmaceuticals, Inc. (NASDAQ:RETA) Is Expected To Breakeven In The Near FutureSeptember 13, 2023 | finance.yahoo.comFirst Light Asset Management LLC Sells 475,525 Shares of Reata Pharmaceuticals, Inc. (NASDAQ:RETA)September 12, 2023 | marketbeat.comDoes Biogen's Latest $1.5 Billion-Dollar Move Make It a Buy?September 9, 2023 | finance.yahoo.comHighTower Advisors LLC Decreases Position in Reata Pharmaceuticals, Inc. (NASDAQ:RETA)September 7, 2023 | marketbeat.comCredit Suisse AG Purchases 2,334 Shares of Reata Pharmaceuticals, Inc. (NASDAQ:RETA)September 1, 2023 | marketbeat.comSwiss National Bank Reduces Stake in Reata Pharmaceuticals, Inc. (NASDAQ:RETA)August 31, 2023 | marketbeat.com3,204 Shares in Reata Pharmaceuticals, Inc. (NASDAQ:RETA) Purchased by Pictet Asset Management SAAugust 30, 2023 | marketbeat.comREATA PHARMACEUTICALS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale ...August 28, 2023 | businesswire.comReata Pharmaceuticals Sees Unusually Large Options Volume (NASDAQ:RETA)August 25, 2023 | marketbeat.comReata Pharmaceuticals, Inc. (NASDAQ:RETA) Receives Consensus Recommendation of "Hold" from AnalystsAugust 24, 2023 | marketbeat.comUS Bancorp DE Purchases 8,947 Shares of Reata Pharmaceuticals, Inc. (NASDAQ:RETA)August 23, 2023 | marketbeat.comStockNews.com Initiates Coverage on Reata Pharmaceuticals (NASDAQ:RETA)August 23, 2023 | marketbeat.comReata Pharmaceuticals, Inc. (NASDAQ:RETA) Shares Acquired by Zurcher Kantonalbank Zurich CantonalbankAugust 20, 2023 | marketbeat.comCantor Fitzgerald Reiterates Reata Pharmaceuticals Inc - (RETA) Neutral RecommendationAugust 15, 2023 | msn.comCantor Fitzgerald Reiterates "Neutral" Rating for Reata Pharmaceuticals (NASDAQ:RETA)August 15, 2023 | marketbeat.comBiondo Investment Advisors LLC Takes $323,000 Position in Reata Pharmaceuticals, Inc. (NASDAQ:RETA)August 11, 2023 | marketbeat.comReata Pharmaceuticals Unusual Options Activity For August 11August 11, 2023 | benzinga.comReata Pharmaceuticals (RETA) Gets a Hold from BarclaysAugust 9, 2023 | markets.businessinsider.comReata Pharmaceuticals (NASDAQ:RETA) Earns Sell Rating from Analysts at StockNews.comAugust 8, 2023 | marketbeat.comEquities Analysts Issue Forecasts for Reata Pharmaceuticals, Inc.'s Q2 2025 Earnings (NASDAQ:RETA)August 4, 2023 | marketbeat.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RETA, EQRX, RVMDAugust 2, 2023 | markets.businessinsider.comReata Pharmaceuticals Inc - (RETA) Price Target Increased by 53.21% to 175.90August 2, 2023 | msn.comIntegrated Wealth Concepts LLC Purchases Shares of 11,294 Reata Pharmaceuticals, Inc. (NASDAQ:RETA)August 1, 2023 | marketbeat.comCitigroup Downgrades Reata Pharmaceuticals (NASDAQ:RETA) to NeutralAugust 1, 2023 | marketbeat.comBiogen's Bold $7.3B Acquisition Of Reata: Analyzing The Impact On InvestorsJuly 29, 2023 | msn.comReata Pharmaceuticals (NASDAQ:RETA) Stock Rating Lowered by SVB SecuritiesJuly 28, 2023 | marketbeat.comBiogen agrees to acquire neurological disease specialist Reata Pharmaceuticals at 60% premiumJuly 28, 2023 | investing.comRETA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Reata Pharmaceuticals, Inc. Is Fair to ShareholdersJuly 28, 2023 | technews.tmcnet.comBiogen to Acquire Reata PharmaceuticalsJuly 28, 2023 | finance.yahoo.comReata Pharmaceuticals Shares Soar on Takeover by Biogen >RETAJuly 28, 2023 | marketwatch.comWhy Is Reata Pharmaceuticals (RETA) Stock Up 53% Today?July 28, 2023 | markets.businessinsider.comReata Pharmaceuticals (Nasdaq:RETA) HeadlineTrading was temporarily halted for "RETA" at 06:07 AM with a stated reason of "News pending."...July 28, 2023 | marketbeat.comExpert Ratings for Reata PharmaceuticalsJuly 24, 2023 | markets.businessinsider.com5,396 Shares in Reata Pharmaceuticals, Inc. (NASDAQ:RETA) Bought by Raymond James Financial Services Advisors Inc.July 20, 2023 | marketbeat.comReata Pharmaceuticals, Inc. (NASDAQ:RETA) Shares Sold by DekaBank Deutsche GirozentraleJuly 16, 2023 | marketbeat.comMoody Aldrich Partners LLC Invests $4.50 Million in Reata Pharmaceuticals, Inc. (NASDAQ:RETA)July 14, 2023 | marketbeat.com Get Reata Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RETA and its competitors with MarketBeat's FREE daily newsletter. Email Address RETA Media Mentions By Week RETA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RETA News Sentiment▼0.000.99▲Average Medical News Sentiment RETA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RETA Articles This Week▼00▲RETA Articles Average Week Get Reata Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RETA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ITCI News Today MOR News Today CALT News Today ZYME News Today CMRX News Today CDMO News Today MBX News Today RVNC News Today CKPT News Today AVTE News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RETA) was last updated on 7/15/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Reata Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Reata Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RETA Stock Alerts